Case studies and perspectives from our work across MedTech, IVD, BioTech, and BioPharma. Filter by type or topic.
25 results
Global life science company
A global life science company engaged us to shape a long-term strategy in general biocatalysis and recombinant enzymes across biopharma, IVD, and industrial applications.
France-based urology MedTech startup
Delivered a comprehensive market opportunity assessment for an early-stage MedTech startup, enabling informed investment and commercialization decisions for a novel endoscope designed for PCNL procedures.
Nordic cardiac MedTech startup
Ran a rapid, statistically robust physician validation program across EU5 markets to test clinical relevance, workflow fit, and adoption potential for a new continuous cardiac monitoring and management system — turning an unproven concept into a quantified, evidence-backed value proposition.
Nordic cardiac MedTech startup
Quantified the US and European market opportunity for a novel CRT (cardiac resynchronization therapy) optimization system and translated physician feedback into a credible commercial and exit narrative for fundraising.
European wound-care innovator
Built an evidence-based market entry strategy for an advanced wound-management solution entering Sweden — sizing the opportunity, mapping regulatory and reimbursement requirements, and identifying the KOLs and distributors needed to launch.
Global medical devices company
A global medical devices company sought to assess the opportunity in India’s value-segment (sub-INR 25,000) hearing aid market and define a practical go-to-market strategy to reach under-served patients with affordable digital devices.
Global medical devices company
A global medical devices company engaged us to map the critical limb ischemia (CLI) and peripheral artery disease (PAD) patient management pathway in India, and to identify and prioritize the biggest unmet needs and white-space opportunities.
Global tissue diagnostics company
A global tissue diagnostics company engaged us to size the India tissue diagnostics market across core histology, special staining, and advanced staining, and to quantify slide volumes, installed base, and competitive share to guide its growth strategy.
Global dental products manufacturer
A global dental products manufacturer engaged us to assess the competitive landscape for chair-side and lab-side products in South Korea and benchmark its brands against global and regional players.
Global dental products manufacturer
A global dental products manufacturer engaged us to assess the competitive landscape for bonding agents and resin cements in Indonesia, covering competitor positioning, pricing, distribution, and customer perceptions.
Japanese medical device manufacturer
A Japanese medical device manufacturer engaged us to identify and profile qualified distribution partners for its physiotherapy and rehabilitation devices in Australia, as Step 1 of our distributor matchmaking programme.
Japanese biopharmaceutical manufacturer
A Japanese biopharmaceutical manufacturer engaged us to identify, profile, and approach distribution partners for its injectable joint-care product in Germany, covering Steps 1 and 2 of our distributor matchmaking programme.
Japanese medical consumables manufacturer
A Japanese medical consumables manufacturer engaged us to identify, profile, and build the business case for distribution partners for its ophthalmic drape product in Singapore, covering Steps 1 and 2 of our distributor matchmaking programme.
Chinese interventional device manufacturer
A Chinese interventional device manufacturer engaged us to identify and profile licensed distribution partners for its coronary and intracranial balloon portfolio in Hong Kong, as Step 1 of our distributor matchmaking programme.
Global dental device manufacturer
A global dental device manufacturer engaged us to run a post-market clinical follow-up survey among dentists in the US and EU5, capturing clinician-reported evidence on the performance, safety, and usability of its endodontic paper points.
Global dental manufacturer
A global dental manufacturer engaged us to run a post-market clinical follow-up survey among dentists in the US and China, capturing clinician-reported evidence on the safety, performance, and esthetics of its sonic-activated bulk-fill composite.
Global dental device manufacturer
A global dental device manufacturer engaged us to run a post-market clinical follow-up survey among general practice dentists in the US, Spain, and Romania, capturing clinician-reported evidence on the performance, safety, and esthetics of its temporary crown and bridge material.
Global dental manufacturer
A global dental manufacturer engaged us to run a post-market clinical follow-up survey among general practice dentists in the US and Russia, capturing clinician-reported evidence on the safety, restoration performance, and esthetics of its shade-matching universal composite.
Global orthodontic device manufacturer
A global orthodontic device manufacturer engaged us to run a post-market clinical follow-up survey among orthodontists and general practice dentists in the US, UK, and Italy, capturing clinician-reported evidence on the safety, usability, and clinical performance of its temporary anchorage device system.
A 150-organization benchmarking study of gender diversity practices across private hospitals and pharmaceutical companies in India, quantifying women's representation from entry level to the board.
A qualitative study with 11 US pulmonologists and IPF specialists on how chronic cough in IPF is managed today and how an investigational therapy would be received.
An ad-hoc qualitative study across the US, UK and China exploring how hospitals decide between upgrading and replacing fixed C-arms, and how new upgrade concepts are received.
PMCF is no longer a box-ticking exercise. A look at what regulators now expect from real-world evidence, and how to build a defensible PMS plan.
Most MedTech markets don't have clean, public procedure data. Here's how triangulation across registries, guidelines, and primary research produces reliable estimates.
The right entry model depends on more than margin. A framework for weighing distributor coverage, control, and speed against a direct commercial build.
Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.
Evidence-led market intelligence, commercialization & clinical evidence for MedTech and BioTech.
contactus@soralifesciences.com© 2026 Sora Life Sciences. All rights reserved.